OASMIA: UNIQUE RESULTS FOR CANCER DRUG PRESENTED IN CAMBRIDGE
March 27, 2007 06:00 ET
|
Oasmia Pharmaceutical AB
Results from a Swedish study shows that two thirds of the dogs that took part
in the research recovered. The unique results were presented in Cambridge on
Sunday.
The study was performed by the...
OASMIA: NEW DRUG FOR TREATMENT OF CANCER IN DOG
March 12, 2007 07:00 ET
|
Oasmia Pharmaceutical AB
It is now possible to treat cancer in dogs in the same way as in humans. This
is the result from a study performed by the company Oasmia Pharmaceutical in
collaboration with the Swedish University...
OASMIA: NYTT CANCERLÄKEMEDEL TILL HUND
March 12, 2007 07:00 ET
|
Oasmia Pharmaceutical AB
Nu blir det möjligt att behandla cancersjuka hundar på samma sätt som hos
människa.
Det visar en studie som läkemedelsföretaget Oasmia Pharmaceutical tillsammans
med Sveriges Lantbruksuniversitet...
OASMIA: OASMIA PHARMACEUTICAL AB (PUBL) PLANERAR ATT BYTA TILL NOTERAD BÖRSLISTA
February 05, 2007 06:00 ET
|
Oasmia Pharmaceutical AB
Oasmia har varit noterat på NGM Nordic MTF sedan 30 december 2005. Mot bakgrund
av företagets starka tillväxt och utveckling samt önskemål från både
institutionella och privata investerare,...
OASMIA: OASMIA PHARMACEUTICAL AB (PUBL) PLANS TRANSFER TO OFFICIAL LISTING
February 05, 2007 06:00 ET
|
Oasmia Pharmaceutical AB
Oasmia has been listed on the NGM Nordic MTF since 30th December 2005. Based on
the company's strong growth and development, along with requests from both
institutional and private investors, Oasmia...
OASMIA: OASMIA ÖPPNAR NYTT AFFÄRSOMRÅDE, ANIMAL HEALTH
February 01, 2007 06:00 ET
|
Oasmia Pharmaceutical AB
Oasmia Pharmaceutical kommer under mars månad att starta en ny division, Animal
Health. Avdelningen kommer främst att inrikta sig på utveckling och
marknadsföring av onkologiprodukter för...
OASMIA: OASMIA ENTERS NEW BUSINESS FIELD, ANIMAL HEALTH
February 01, 2007 06:00 ET
|
Oasmia Pharmaceutical AB
Oasmia Pharmaceutical will launch a new division, Animal Health, during March
of this year. The division will focus on development and marketing of oncology
products for companion animals where the...
OASMIA: NEW OASMIA-PRODUCT READY FOR CLINICAL TRIALS
January 31, 2007 06:00 ET
|
Oasmia Pharmaceutical AB
Oasmia Pharmaceutical's third patented product, Doxophos®, is now ready to
enter clinical trials. The trials are planned to commence during the fourth
quarter of 2007.
Doxophos® contains the...
OASMIA: NÄSTA OASMIA-PRODUKT REDO FÖR KLINISKA PRÖVNINGAR
January 31, 2007 06:00 ET
|
Oasmia Pharmaceutical AB
Oasmia Pharmaceuticals tredje patenterade produkt för cancerbehandling,
Doxophos®, är nu redo för kliniska prövningar. Prövningarna är planerade att
inledas under fjärde kvartalet 2007....